AOU City of Health and Science of Turin

Turin, Torino 10126

0 studies enrolling now · 1 studies all time

What they study most

Relapsed/Refractory Diffuse Large B-cell Lymphoma

Studies at this site

• A Study of Rituximab-Gemcitabine-Dexamethasone-Platinum (R-GDP) With or Without Selinexor in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma — Running, not enrolling